IBDEI0NN ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10643,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,10643,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,10644,0)
 ;;=F01.51^^42^472^49
 ;;^UTILITY(U,$J,358.3,10644,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10644,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob VASCULAR DISEASE w/ Behav Disturb
 ;;^UTILITY(U,$J,358.3,10644,1,4,0)
 ;;=4^F01.51
 ;;^UTILITY(U,$J,358.3,10644,2)
 ;;=^5003047
 ;;^UTILITY(U,$J,358.3,10645,0)
 ;;=F01.50^^42^472^50
 ;;^UTILITY(U,$J,358.3,10645,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10645,1,3,0)
 ;;=3^Major Neurocog D/O d/t Prob VASCULAR DISEASE w/o Behav Disturb
 ;;^UTILITY(U,$J,358.3,10645,1,4,0)
 ;;=4^F01.50
 ;;^UTILITY(U,$J,358.3,10645,2)
 ;;=^5003046
 ;;^UTILITY(U,$J,358.3,10646,0)
 ;;=G31.84^^42^472^66
 ;;^UTILITY(U,$J,358.3,10646,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10646,1,3,0)
 ;;=3^Mild Neurocog D/O d/t VASCULAR DISEASE
 ;;^UTILITY(U,$J,358.3,10646,1,4,0)
 ;;=4^G31.84
 ;;^UTILITY(U,$J,358.3,10646,2)
 ;;=^5003813
 ;;^UTILITY(U,$J,358.3,10647,0)
 ;;=R41.9^^42^472^69
 ;;^UTILITY(U,$J,358.3,10647,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10647,1,3,0)
 ;;=3^Neurocognitive Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,10647,1,4,0)
 ;;=4^R41.9
 ;;^UTILITY(U,$J,358.3,10647,2)
 ;;=^5019449
 ;;^UTILITY(U,$J,358.3,10648,0)
 ;;=Z21.^^42^472^22
 ;;^UTILITY(U,$J,358.3,10648,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10648,1,3,0)
 ;;=3^HIV Positive/Infection Status
 ;;^UTILITY(U,$J,358.3,10648,1,4,0)
 ;;=4^Z21.
 ;;^UTILITY(U,$J,358.3,10648,2)
 ;;=^5062777
 ;;^UTILITY(U,$J,358.3,10649,0)
 ;;=F06.31^^42^473^1
 ;;^UTILITY(U,$J,358.3,10649,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10649,1,3,0)
 ;;=3^Depressive Disorder d/t Another Med Cond w/ Depressive Features
 ;;^UTILITY(U,$J,358.3,10649,1,4,0)
 ;;=4^F06.31
 ;;^UTILITY(U,$J,358.3,10649,2)
 ;;=^5003057
 ;;^UTILITY(U,$J,358.3,10650,0)
 ;;=F06.32^^42^473^2
 ;;^UTILITY(U,$J,358.3,10650,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10650,1,3,0)
 ;;=3^Depressive Disorder d/t Another Med Cond w/ Major Depressive-Like Episode
 ;;^UTILITY(U,$J,358.3,10650,1,4,0)
 ;;=4^F06.32
 ;;^UTILITY(U,$J,358.3,10650,2)
 ;;=^5003058
 ;;^UTILITY(U,$J,358.3,10651,0)
 ;;=F32.9^^42^473^17
 ;;^UTILITY(U,$J,358.3,10651,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10651,1,3,0)
 ;;=3^MDD,Single Episode,Unspec
 ;;^UTILITY(U,$J,358.3,10651,1,4,0)
 ;;=4^F32.9
 ;;^UTILITY(U,$J,358.3,10651,2)
 ;;=^5003528
 ;;^UTILITY(U,$J,358.3,10652,0)
 ;;=F32.0^^42^473^13
 ;;^UTILITY(U,$J,358.3,10652,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10652,1,3,0)
 ;;=3^MDD,Single Episode,Mild
 ;;^UTILITY(U,$J,358.3,10652,1,4,0)
 ;;=4^F32.0
 ;;^UTILITY(U,$J,358.3,10652,2)
 ;;=^5003521
 ;;^UTILITY(U,$J,358.3,10653,0)
 ;;=F32.1^^42^473^14
 ;;^UTILITY(U,$J,358.3,10653,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10653,1,3,0)
 ;;=3^MDD,Single Episode,Moderate
 ;;^UTILITY(U,$J,358.3,10653,1,4,0)
 ;;=4^F32.1
 ;;^UTILITY(U,$J,358.3,10653,2)
 ;;=^5003522
 ;;^UTILITY(U,$J,358.3,10654,0)
 ;;=F32.2^^42^473^16
 ;;^UTILITY(U,$J,358.3,10654,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10654,1,3,0)
 ;;=3^MDD,Single Episode,Severe w/o Psychotic Feat
 ;;^UTILITY(U,$J,358.3,10654,1,4,0)
 ;;=4^F32.2
 ;;^UTILITY(U,$J,358.3,10654,2)
 ;;=^5003523
 ;;^UTILITY(U,$J,358.3,10655,0)
 ;;=F32.3^^42^473^15
 ;;^UTILITY(U,$J,358.3,10655,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10655,1,3,0)
 ;;=3^MDD,Single Episode,Severe w/ Psychotic Feat
